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ABSTRACT
Background: ST-segment resolution is an important predictor 
of infarct-related artery patency and effective microcircula-
tory perfusion. The aim of this study was to compare patients 
with and without ST-segment elevation resolution and iden-
tify variables that are associated with failure of ST-segment 
resolution. Methods: Between March 2012 and July 2013, 61 
patients with ST-segment elevation acute myocardial infarction 
underwent primary percutaneous coronary intervention (PCI) 
and were included in a prospective registry. To compare the 
groups with and without ST-segment resolution, the chi-square 
test or Fisher’s exact test were used for qualitative variables 
and Student’s t test or Mann-Whitney’s test for quantitative 
variables. Simple and multiple logistic regression models were 
used to identify variables associated with failure of ST-segment 
resolution. Results: The group of patients without ST-segment 
resolution had higher heart rate, higher prevalence of diabe-
tes mellitus, chronic renal failure and a trend towards longer 
ischemia time. There was a higher mortality rate in patients 
who did not achieve ST-segment elevation resolution. In the 
univariate analysis, heart rate, diabetes mellitus, chronic renal 
failure and ischemia time were associated with increased odds 
of not obtaining ST-segment resolution, losing significance in 
the multivariate model. Conclusions: Failure of ST-segment 
resolution is observed in up to one-third of patients undergo-
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RESUMO
Resolução do Segmento ST após Intervenção 
Coronária Percutânea Primária: Características, 
Preditores de Insucesso e Impacto na Mortalidade
Introdução: A resolução do segmento ST é um importante 
preditor de patência da artéria relacionada ao infarto e de 
perfusão efetiva da microcirculação. O objetivo deste trabalho 
foi comparar pacientes com e sem resolução do segmento 
ST e identificar variáveis que se associam à não resolução 
do ST. Métodos: Entre março de 2012 e julho de 2013, 61 
pacientes com infarto agudo do miocárdio com elevação 
do segmento ST foram submetidos à intervenção coronária 
percutânea (ICP) primária e incluídos em um registro pro-
spectivo. Para comparar os grupos com e sem resolução do 
segmento ST, foi utilizado o teste qui-quadrado ou exato de 
Fisher, para as variáveis qualitativas, e o teste t de Student ou 
de Mann-Whitney, para variáveis quantitativas. Para identificar 
variáveis associadas à não resolução do ST, foram ajustados 
modelos de regressão logística simples e múltipla. Resulta-
dos: O grupo de pacientes sem resolução do segmento ST 
apresentou maior frequência cardíaca, maior prevalência de 
diabetes mellitus, de insuficiência renal crônica e tendência 
a maior tempo de isquemia. Observou-se maior mortalidade 
hospitalar entre pacientes que não obtiveram resolução do 
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ing primary PCI and requires new pharmacologic strategies 







DESCRIPTORS: Myocardial infarction. Percutaneous coronary 
intervention. Myocardial reperfusion.
This study aimed to compare demographic and 
procedure-related characteristics of patients with and 
without complete ST-segment resolution after perform-
ing primary PCI, and to identify the variables that 
were associated to non-ST-resolution. The secondary 
objective was to determine its impact on infarct size, 
measured by maximum peak of CK-MB, length of stay, 
and in-hospital mortality after 30 days, six months and 
one year of follow-up.
Ischemia time was defined as the interval between 
the onset of symptoms and the crossing of the lesion 
with a pre-dilation balloon, manual thrombus aspiration 
catheter, or stent. Door-to-balloon time was defined as 
the interval between hospital admission and the crossing 
of the lesion with a pre-dilation balloon catheter, manual 
thrombus aspiration catheter, or stent. A CK-MB analysis 
was performed every six hours until the occurrence of 
a reduction in the levels of this biomarker. The choice 
of antiplatelet therapy, use of prophylactic intracoronary 
adenosine, manual aspiration thrombectomy, and the 
access route were left to the discretion of the surgeon.
Statistical Analysis
Qualitative variables were summarized as absolute 
frequencies and percentages. The quantitative data were 
expressed as means ± standard deviation or medians 
and interquartile ranges (25th percentile –75th per-
centile) according to distribution for each variable. To 
compare the groups with and without resolution of the 
ST-segment, the chi-squared test or Fisher’s exact test 
were used for qualitative variables, and Student’s t-test 
or the Mann-Whitney test were used for quantitative 
variables.
To identify variables associated with ST-segment 
resolution, simple (univariate approach) and multiple 
(multivariate analysis) logistic regression models were 
adjusted. The results were expressed as odds ratios (OR) 
and 95% confidence intervals (95% CI). The level of 
significance was 0.05. The statistical program used to 
perform the calculations was the SPSS for Windows, 
version 19.0.
ST. Pela análise univariada, as variáveis frequência cardíaca, 
diabetes mellitus, insuficiência renal crônica e tempo de 
isquemia associaram-se à maior chance de não resolução do 
ST, perdendo significância no modelo multivariado. Conclusões: 
A não resolução do segmento ST pode ocorrer em até um 
terço dos pacientes submetidos à ICP primária, requerendo o 
advento de novas estratégias farmacológicas ou de intervenção 
capazes de minimizá-la.
DESCRITORES: Infarto do miocárdio. Intervenção coronária 
percutânea. Reperfusão miocárdica.
C ompared to fibrinolysis, percutaneous coronary intervention (PCI) promotes a more early and sustained restoration of epicardial flow in the 
target vessel, and is widely accepted as the preferred 
strategy in the treatment of acute myocardial infarc-
tion (AMI).1,2 The resolution of the ST-segment after 
the institution of reperfusion therapy is an important 
predictor of patency of the artery related to the event 
and of effective microcirculatory perfusion.3
The analysis of ST-segment resolution on the elec-
trocardiogram (ECG) consists of a simple tool, of easy 
use and low cost, able to document success of the epi-
cardial reperfusion and tissue reperfusion after primary 
PCI.4 The persistence of ST-segment elevation on the 
ECG, despite the restoration of a normal epicardial flow, 
signifies a poor prognosis; such persistence is known 
to be associated with larger infarct size and higher 
combined rate of severe cardiovascular adverse events.5
In a contemporary context for the application 
of primary PCI, characterized by an aggressive anti-
thrombotic therapy, manual aspiration thrombectomy, 
intracoronary adenosine, and ample use of the radial 
access, this study aimed to determine the percentage 
of failure in ST-segment resolution, its predictors, and 
the impact on in-hospital and late mortality.
METHODS
Between March 2012 and July 2013, patients with 
AMI with ST-segment elevation ≥ 1 mm in two contigu-
ous leads of the frontal plane or ≥ 2 mm in precordial 
leads, with symptoms duration < 12 hours, underwent 
primary PCI and were included in a local controlled 
prospective registry. A 12-lead ECG, plus leads V3R, 
V4R, V7, and V8 in the case of lower AMI, was per-
formed at admission and 30 to 60 minutes after the 
conclusion of the procedure. Patients with left branch 
block or pacemaker rhythm, surgical myocardial re-
vascularization, cardiogenic shock, or life expectation 
< six months were excluded. The electrocardiographic 
analysis followed the prevalent normative guidelines,6 
considering complete a ST-segment resolution > 70%.
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Comparisons among patients with and without 
ST-segment resolution
Table 1 shows a comparison among patients with 
and without ST-segment resolution regarding baseline 
clinical characteristics. It was observed that the group of 
patients without ST-segment resolution had, on average, 
a higher heart rate and higher prevalence of diabetes 
mellitus and of chronic renal failure.
With respect to the procedure and angiographic 
characteristics (Table 2), a statistically significant dif-
ference was observed only in the number of stents 
used. A trend of longer ischemia time among patients 
without ST-segment resolution (4.7 ± 2.0 hours vs. 6.3 
± 3.1 hours; P = 0.07) was detected. 
Regarding the results and the clinical outcome, a 
higher in-hospital mortality rate among patients who 
did not achieve ST-segment resolution was observed 
(Table 3).
Identification of variables associated with  
non-ST segment resolution
This part of the analysis sought to identify, among 
the clinical, angiographic and procedural characteristics, 
the factors associated with the increased probability of 
non-ST-segment resolution. Initially, the isolated effect 
of each variable were investigated by simple logistic 
regression models (univariate analysis), considering as 
dependent variable the non-ST-segment resolution. The 
results are shown in Table 4.
As expected, according to the comparison between 
groups, the variables heart rate, diabetes mellitus, and 
chronic renal failure were associated with increased 
probability of non ST-segment resolution. In addition, 
the ischemia time was also significant. The variables 
prior AMI, prior PCI, route of access, and therapeutic 
catheters could not be analyzed due to the low fre-
quency in some of their categories.
Variables with P <  0.20 in the univariate analysis 
were selected for the multivariate model, in which the 
effects were analyzed simultaneously (Table 5). In this 
model, all variables lost their importance and ceased to 
be significant according to the usual significance level 
of 0.05. This can be explained by the low statistical 
power to detect differences, caused by the increase in 
the number of parameters in the model.
In order to obtain a more consistent model, the 
non-significant variables were excluded, step-by-step, 
until the achievement of a reduced model. In this model, 
only diabetes (OR = 3.83, 95% CI, 1.17 to 12.51, P = 
0.19) and chronic renal failure (OR = 8.75, 95% CI, 1.50 
to 50.90, P = 0.15) remained significant. Importantly, 
although they were significant, the estimates were not 
very accurate (very wide CIs), and the ORs may be 
overestimated. Still, it is clear that diabetes mellitus 
and chronic renal failure are factors associated with 
non-ST-segment resolution.
DISCUSSION
Incomplete ST-segment resolution after primary 











(n = 17) P
Male, n (%) 34 (55.7) 26 (59.1) 8 (47.1) 0.40
Age, years 58.8 ± 10.8 59.2 ± 11.2 57.6 ± 9.8 0.61
BMI, kg/m2 28.0 ± 4.6 27.8 ± 4.9 28.5 ± 4.0 0.60
HR, bpm 82.4 ± 17.1 79.4 ± 16.4 90.1 ± 16.7 0.03
Hypertension, n (%) 42 (68.9) 30 (68.2) 12 (70.6) 0.86
Diabetes mellitus, n (%) 19 (31.1) 10 (22.7) 9 (52.9) 0.02
Currently smoking (%) 24 (39.3) 20 (45.5) 4 (23.5) 0.12
Prior AMI, n (%) 3 (4.9) 3 (6.8) 0 0.55
Prior PCI, n (%) 3 (4.9) 3 (6.8) 0 0.55
Creatinine, mg/dL 0.81 (0.67-1.06) 0.79 (0.64-1.02) 0.89 (0.76-1.49) 0.15
Chronic renal failure, n (%) 7 (11.5) 2 (4.5) 5 (29.4) 0.02
BMI = body mass index; HR = heart rate; bpm = beats per minute; AMI = acute myocardial infarction; PCI = percutaneous coronary 
intervention.
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(n = 17) P
Killip I, n (%) 57 (93.4) 41 (93.2) 16 (94.1) > 0.99
Location of AMI, n (%) 0.72
Anterior 30 (49.2) 21 (47.7) 9 (52.9)
Inferior 31 (50.8) 23 (52.3) 8 (47.1)
Hemoglobin, g/dL 13.7 ± 1.9 13.9 ± 1.9 13.1 ± 2.0 0.15
CK-MB activity, U/L 51.5 (26.9-115) 52.3 (27-107.5) 48.2 (23-121) 0.94
Ischemia time, hours 5.1 ± 2.4 4.7 ± 2.0 6.3 ± 3.1 0.07
Door-to-balloon time, min 55 (42-75) 56.5 (43.5-80) 50.0 (42-65) 0.40
Manual aspiration 
thrombectomy, n (%) 
33 (54.1) 23 (52.3) 10 (58.8) 0.45
Direct stent implantation, n (%) 27 (44.3) 21 (47.7) 6 (35.3) 0.38
Visible aspirated, n (%) 19 (31.1) 14 (31.8) 5 (29.4) 0.86
Prophylactic adenosine, n (%) 22 (36.1) 16 (36.4) 6 (35.3) 0.94
TIMI pre-0 or 1, n (%) 49 (80.3) 37 (84.1) 12 (70.6) 0.29
Radial access, n (%) 60 (98.4) 43 (97.7) 17 (100) > 0.99
GPI IIb/IIIa, n (%) 35 (59.3) 24 (57.1) 11 (64.7) 0.59
Left ventriculography, n (%) 0.55
Not evaluated 8 (13.1) 6 (13.6) 2 (11.8)
Normal 18 (29.5) 13 (29.5) 5 (29.4)
Mild dysfunction 16 (26.2) 11 (25.0) 5 (29.4)
Moderate dysfunction 16 (26.2) 13 (29.5) 3 (17.6)
Severe dysfunction 3 (4.9) 1 (2.3) 2 (11.8)
Culprit vessel, n (%) > 0.99
Left anterior descending artery 29 (47.6) 21 (47.7) 8 (47.1)
Right coronary artery 19 (31.1) 14 (31.8) 5 (29.4)
Left circumflex artery 12 (19.7) 8 (18.2) 4 (23.5)
Intermediate branch 1 (1.6) 1 (2.3) 0
P2Y12 blocker, n (%) 0.70
Clopidogrel 300 mg 4 (6.6) 3 (6.8) 1 (5.9)
Clopidogrel 600 mg 38 (62.3) 26 (59.1) 12 (70.6)
Ticagrelor 180 mg 19 (31.1) 15 (34.1) 4 (23.5)
Number of diagnostic catheters 1 (1-2) 1 (1-2) 1 (1-2) 0.91
Diagnostic catheters, n (%) > 0.99
1 44 (72.1) 32 (72.7) 12 (70.6)
2 or more 17 (27.9) 12 (27.3) 5 (29.4)
Number of therapeutic catheters 1 (1-1) 1 (1-1) 1 (1-1) 0.15
Therapeutic catheters, n (%) 0.31
1 56 (91.8) 39 (88.6) 17 (100.0)
2 or 3 5 (8.2) 5 (11.4) 0
Number of stents 1 (1-1) 1 (1-1) 1 (1-1) 0.01
Number of stents, n (%) < 0.01
0 4 (6.6) 0 4 (23.5)
1 50 (82.0) 38 (86.4) 12 (70.6)
2 or 3 7 (11.5) 6 (13.6) 1 (5.9)
Contrast volume, mL 185.8 ± 64.1 187.8 ± 66.4 180.6 ± 59.2 0.70
AMI = acute myocardial infarction; GPI = glycoprotein inhibitor.
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resolution. Initially, the sample of patients undergoing 
the procedure was restricted to within 12 hours after 
onset of symptoms. The mean ischemia time was 5.1 
hours and the median door-to-balloon time was only 55 
minutes, favored by the logistical conditions set forth 
in a previous publication.10 Moreover, manual aspira-
tion thrombectomy was used in 54% of the sample, 
and glycoprotein IIb/IIIa inhibitors and adenosine were 
administered prophylactically to 59% and 36% of cases, 
respectively.
In fact, in the electrocardiographic sub-analysis 
of the trial Platelet Inhibition and Patient Outcomes 
(PLATO),11 70% of patients randomized in the interval 
of 3-6 hours from the onset of symptoms exhibited 
ST-segment resolution, compared to 51% of those 
randomized after 6 hours. Meanwhile, a meta-analysis 
including 18 randomised trials and 3,936 patients 
showed that manual thrombus aspiration, compared 
to conventional primary PCI, promotes higher TIMI 3 
final myocardial blush (63.6% vs. 48.5%; P < 0.0001) 
and higher complete ST-segment resolution (55.8% vs. 
44.3%; P <  0.0001).12
Glycoprotein IIb/IIIa inhibitors, despite lack of 
consistent evidence to justify their routine indication, 
find an application niche in patients classified as high 
risk.13,14 Finally, in the “Intracoronary Nitroprusside Versus 
Adenosine in Acute Myocardial Infarction”(REOPEN-AMI) 
randomized trial, 71% of patients who received intra-
coronary adenosine after thrombus aspiration exhibited 
ST-segment resolution > 70%, compared to 54% in the 
group receiving sodium nitroprusside and to 51% of 
regardless of the degree of patency of the target vessel.5 
In a series from real-world practice, characterized by a 
mean age of 59 years, 31% diabetics, 11% with chronic 
renal failure, ischemia time of 5 hours, and median 
door-to-balloon time of 55 minutes, the rate of obtain-
ing a final Thrombolysis in Myocardial Infarction (TIMI) 
flow 3 was 84%, with ST-segment resolution > 70% in 
72% of the sample. Diabetes mellitus, chronic renal 
failure, elevated heart rate, longer ischemic time, and 
fewer implanted stents were the characteristics most 
commonly observed in patients who did not achieve 
ST-segment resolution; the first two factors are important 
predictors of failure.
In pre-specified analysis of the randomized trial 
“Harmonizing Outcomes with Revascularization and 
Stents in Acute Myocardial Infarction” (HORIZONS-
AMI), comprising 2,484 of 3,345 patients undergoing 
primary PCI, the rate of resolution of ST-segment > 
70% was 50.5%, with a lower incidence of death, 
reinfarction, target vessel revascularization, and stent 
thrombosis at three years in this group.7 In the same 
clinical trial, final TIMI flow 3 was achieved in 87.1% 
of the sample, and age, anterior wall AMI, TIMI pre-
0/1, and extent of injury were independent predictors 
of final TIMI flow <  3 by multivariate analysis.8 In an 
Argentinean multicenter registry, despite obtaining a 
final TIMI flow 3 in 90% of the sample, the rate of 
complete ST-segment resolution was 48.5%.9
The present series displays characteristics that 
differ from those previously mentioned, which could 
explain the high percentage of complete ST-segment 
TABLE 3 









(n = 17) P
TIMI 3post, n (%) 51 (83.6) 39 (88.6) 12 (70.6) 0.12
CK-MB peak, U/L 285.9 ± 206.2 295.2 ± 194.6 261.9 ± 238.4 0.58
Length of hospital stay, nights 3 (3-4) 3 (3-4) 4 (3-5) 0.53
Complications, n (%) 6 (9.8) 3 (6.8) 3 (17.6) 0.34
In-hospital mortality, n (%) 4 (6.6) 0 4 (23.5) < 0.01
Clinical events at 30 days, n (%) 
Patients 51 38 13
Events 1 (1.9) 1 (2.6) 0 > 0.99
Clinical events at six months, n (%) 
Patients 37 28 9
Events 3 (8.1) 3 (10.7) 0 0.55
Clinical events at one year, n (%) > 0.99
Patients 24 17 7
Events 2 (8.3) 2 (11.8) 0
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Factors associated with non-ST-segment resolution (univariate analysis)
Variables OR 95% CI P
Male 0.62 (0.20-1.90) 0.40
Age, years 0.99 (0.94-1.04) 0.61
Body mass index, kg/m2 1.03 (0.92-1.17) 0.59
Heart rate, ×10 bpm 1.47 (1.03-2.10) 0.03
Hypertension 1.12 (0.33-3.80) 0.86
Diabetes mellitus 3.83 (1.17-12.51) 0.03
Current smoking 0.37 (0.10-1.31) 0.12
Creatinine, mg/dL 1.10 (0.74-1.62) 0.64
Chronic renal failure 8.75 (1.50-50.90) 0.02
Killip I 1.17 (0.11-12.10) 0.90
Infarction, anterior location 1.23 (0.40-3.78) 0.72
Hemoglobin on admission, g/dL 0.80 (0.60-1.08) 0.15
CK-MB activity on admission, U/L 1.00 (0.10-1.01) 0.33
Ischemia time, hours 1.31 (1.03-1.68) 0.03
Door-to-balloon time, min 0.10 (0.98-1.02) 0.86
Manual aspiration thrombectomy 1.30 (0.42-4.05) 0.65
Direct stent implantation 0.60 (0.19-1.90) 0.38
Macroscopic aspirate visible 0.89 (0.26-3.03) 0.86
Prophylactic adenosine 0.96 (0.30-3.07) 0.94
TIMI pre-2 or 3 2.20 (0.59-8.24) 0.24
Glycoprotein IIb/IIIa inhibitor 1.38 (0.43-4.42) 0.59
Moderate or severe LV 0.89 (0.26-3.03) 0.86
Culprit vessel 
Right coronary 1.00 – –
Left Circumflex artery/intermediate branch 1.24 (0.26-5.92) 0.78
Left anterior Descending artery 1.07 (0.29-3.94) 0.92
P2Y12 blocker on admission 
Ticagrelor 180 mg 1.00 – –
Clopidogrel 300 mg 1.25 (0.10-15.50) 0.86
Clopidogrel 600 mg 1.73 (0.47-6.34) 0.41
2 or more diagnostic catheters 1.11 (0.32-3.83) 0.87
2 or more stents 0.40 (0.04-3.56) 0.41
OR = odds ratio; IC 95% = confidence interval of 95%; bpm = beats per minute.
TABLE 5 
Factors associated with non-ST-segment resolution. Results of simple (univariate analysis)  
and multiple (multivariate analysis) logistic regression models 
Factors 
Univariate Multivariate
OR 95% CI P OR 95% CI P
Heart rate, ×10 bpm 1.47 (1.03-2.10) 0.03 1.42 (0.93-2.18) 0.11
Diabetes mellitus 3.83 (1.17-12.51) 0.03 2.55 (0.63-10.31) 0.19
Current smoking 0.37 (0.10-1.31) 0.12 0.55 (0.12-2.46) 0.43
Chronic renal failure 8.75 (1.50-50.90) 0.02 4.41 (0.57-33.97) 0.15
Hemoglobin at admission, g/dL 0.80 (0.60-1.08) 0.15 0.84 (0.55-1.28) 0.41
Ischemia time, hours 1.31 (1.03-1.68) 0.03 1.22 (0.90-1.65) 0.21
OR = odds ratio; IC 95% = confidence interval of 95%.
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the saline group (P  =  0.009), limiting the reperfusion 
injury, as measured by the occurrence of angiographic 
microvascular obstruction (TIMI flow ≤ 2 or 3 with TIMI 
myocardial blush <  2).15
Limitations of the study
Apart from the non-random sampling, the main 
limitation of this study resided in the small size of 
their sample, making it impossible to identify potential 
determinant variables for failure of complete ST-segment 
resolution after primary PCI.
CONCLUSIONS
Incomplete resolution of ST-segment may occur in up 
to one-third of patients undergoing primary percutane-
ous coronary intervention, regardless of the restoration 
of TIMI 3 final epicardial flow. The predictor variables 
diabetes mellitus, chronic renal failure, heart rate, and 
ischemia time are associated with incomplete resolution 
of ST-segment elevation, requiring new pharmacological 
or interventional strategies to minimize this condition.
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